Alternative Immunotherapy Drug More Effective than Current Standard of Care in Treating Advanced Melanoma after … – PR Newswire (press release)
PR Newswire (press release) |
Alternative Immunotherapy Drug More Effective than Current Standard of Care in Treating Advanced Melanoma after …
PR Newswire (press release) NEW YORK, Sept. 10, 2017 /PRNewswire-USNewswire/ — The immunotherapy drug nivolumab is safer and more effective than ipilimumab—the current standard of care—in treating patients with resected stage III and stage IV melanoma, according to an … |
